Healthcare -
Biotechnology - NASDAQ - US
$ 16.5
0.671 %
$ 3.9 B
Market Cap
61.11
P/E
ADMA - REVENUE
Revenue ADMA - ADMA Biologics, Inc.
258 M
LAST VALUE
78.61%
2 YEAR CAGR
72.34%
5 YEAR CAGR
55.78%
10 YEAR CAGR